Quantcast

Latest Diabetes mellitus type 1 Stories

2014-07-21 12:24:39

Passionate volunteer will now lead organization toward life-changing treatments on path to ultimate cure for type one diabetes (T1D) NEW YORK, July 21, 2014 /PRNewswire/ -- JDRF's International Board of Directors (IBOD) announced today the appointment of Derek Rapp, currently Vice Chair of the JDRF International Board of Directors, as its new President and CEO. http://photos.prnewswire.com/prnvar/20140721/128866 Rapp replaces Jeffrey Brewer who recently left his role as JDRF...

2014-07-18 16:23:18

DUBLIN, July 18, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3txjqf/global_type_1) has announced the addition of the "Global Type 1 Diabetes Market 2014-2018" [http://www.researchandmarkets.com/research/3txjqf/global_type_1 ] report to their offering. Type 1 diabetes is an autoimmune disorder characterized by high blood glucose levels. In this condition, the immune system is activated against self-insulin producing cells. This,...

2014-07-17 23:05:17

Over the last two years, a dream team of diverse and talented scientists has been assembled at the University of Iowa’s Fraternal Order of Eagles Diabetes Research Center (FOEDRC) in collaboration to find new keys to preventing and curing this devastating disease. The community service organization Fraternal Order of Eagles (FOE) presented a $6 million donation to the University of Iowa at its national convention on Sunday, July 13, fulfilling a $25 million commitment made in 2008. Los...

2014-07-17 16:25:37

NEW YORK, July 17, 2014 /PRNewswire/ -- JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today ViaCyte, Inc., a leading regenerative medicine company, has filed an Investigational New Drug application (IND) with the U.S. Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of the VC-01(TM) product candidate, a stem...

2014-07-17 08:30:21

SAN DIEGO, July 17, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a cell replacement therapy for the treatment of diabetes, today announced that it has filed an Investigational New Drug application (IND) with the United States Food and Drug Administration (FDA) seeking to initiate a Phase 1/2 clinical trial in patients with type 1 diabetes. The trial would evaluate the safety and efficacy of ViaCyte's VC-01(TM) product candidate, a stem...

2014-07-16 20:22:30

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Global Insulin Market Outlook 2018 https://www.reportbuyer.com/product/2080565/Global-Insulin-Market-Outlook-2018.html About 381 Million people suffered from diabetes in 2013 globally, which is likely to reach 591 Million by 2035. The growing number of diabetes patients at such a high pace significantly increases the demand for insulin products. The discovery of Insulin therapy has...

Labeling People With Pre-diabetes Is Unhelpful And Unnecessary
2014-07-15 03:31:56

University College London Labeling people with moderately high blood sugar as pre-diabetic is a drastically premature measure with no medical value and huge financial and social costs, say researchers from UCL and the Mayo Clinic, Minnesota. The analysis, published in the BMJ, considered whether a diagnosis of pre-diabetes carried any health benefits such as improved diabetes prevention. The authors showed that treatments to reduce blood sugar only delayed the onset of type 2 diabetes...

The doctor takes from the child blood.
2014-07-14 05:29:20

redOrbit Staff & Wire Reports - Your Universe Online Researchers from the Stanford University School of Medicine have developed an inexpensive and portable new device that uses nanotechnology to diagnose type-1 diabetes – a breakthrough they claim could improve patient care worldwide and help medical experts better understand the condition. The inventors, who detailed their work Sunday in the journal Nature Medicine, explain that the purpose of their new handheld microchip is to...

2014-07-11 10:08:10

University of Copenhagen – The Faculty of Health and Medical Sciences A number of studies suggest that children delivered by Caesarean section have a different intestinal flora than children delivered by natural birth. But it is still unknown why this is the case and what it means for the immune system. Researchers from the Faculty of Health and Medical Sciences therefore decided to scrutinize the impact of birth on the development of the immune system in a study of newborn mouse pups....

2014-07-09 08:27:32

Trial to Evaluate Efficacy and Safety of LX4211 in Younger Population THE WOODLANDS, Texas, July 9, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that JDRF, the world's largest non-profit supporter of type 1 diabetes (T1D) research, will provide funding to support a Phase 2, randomized, double-masked, placebo-controlled clinical trial to evaluate the efficacy and safety of LX4211 in a younger population with T1D. Up to 76 individuals with T1D,...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'